KLCM Advisors Actively Rebalances Portfolio, Boosts Lam Research and Adds ADP in Q1

Lam Research has a high institutional stake, with 84.61% of its stock owned by institutional investors, highlighting broad professional involvement in the name.
Analysts weighed in on Lam Research in the first quarter, with New Street Research raising its target to 280 (neutral), Goldman Sachs reiterating a Buy with a 290 target, Stifel Nicolaus lifting its objective to 425 (Buy), and Oppenheimer maintaining an Outperform rating with a 400 target (up from 330).
Bristol Myers Squibb (BMY) is the 15th largest holding in KLCM’s portfolio, illustrating its role as a mid-sized position within the overall mix.
Truist Financial (TFC) is the 17th largest holding in KLCM’s portfolio, comprising about 1.4% of the overall allocation and valued at roughly $16.25 million.
In Texas Pacific Land, while KLCM trimmed its stake by 11.9%, other institutions increased their positions, notably Bar Harbor Wealth Management (+195.1% to 36,873 shares) and Stratos Wealth Partners (+212.9% to 18,211 shares).
KLCM Advisors Inc. boosted its stake in Lam Research by 11% in the first quarter, adding 1,646 shares to reach a total of 16,663 shares worth about $3.56 million, according to Watchlist News. The move signals growing confidence in semiconductor equipment as the firm actively reshuffles holdings across tech, finance, and healthcare.
At the same time, KLCM made a fresh bet on payroll giant Automatic Data Processing, picking up 9,991 shares worth roughly $2.03 million. The new position came alongside a mix of cuts and additions across the portfolio, showing a firm in active rebalancing mode.
KLCM's 11% increase in Lam Research comes as Wall Street analysts turn more bullish on the chipmaker. Goldman Sachs reiterated a Buy rating with a $290 price target. Stifel Nicolaus lifted its target to $425, also with a Buy rating. Oppenheimer kept its Outperform rating and raised its target from $330 to $400, according to Watchlist News.
Institutional investors broadly share KLCM's enthusiasm. A full 84.61% of Lam Research stock is held by institutional investors. New Street Research also weighed in, raising its target to $280 with a neutral stance. The stock has wide professional support across the board.
KLCM trimmed its Bristol Myers Squibb stake by 6.2%, selling down to 300,430 shares valued at about $18.22 million, per Watchlist News. Bristol Myers is the firm's 15th largest holding. It makes up roughly 1.5% of the total portfolio. The cut suggests a modest pullback, not an exit.
Meanwhile, KLCM added to its Truist Financial position, growing it by 6.0% to 353,458 shares worth about $16.25 million. Truist ranks as the 17th largest holding at about 1.4% of the portfolio. The increase shows the firm still sees value in regional banking names despite a choppy rate environment.
KLCM reduced its Texas Pacific Land position by 11.9%, bringing its total to 25,990 shares worth about $12.33 million, according to Watchlist News. The cut stands out in a natural resources name that other institutions were actively buying. It shows KLCM taking a different view from the crowd.
Bar Harbor Wealth Management grew its Texas Pacific Land stake by 195.1% to 36,873 shares. Stratos Wealth Partners went even further, up 212.9% to 18,211 shares. While peers piled in, KLCM chose to scale back — a clear sign of selective, conviction-driven portfolio management.
KLCM's new 9,991-share position in Automatic Data Processing totals roughly $2.03 million. ADP is a payroll and human resources software giant. The purchase fits a broader pattern of adding large, stable tech-adjacent businesses to the portfolio, per Ticker Report.
The firm also cut its U.S. Bancorp stake by 15.0%, down to 111,552 shares, according to Ticker Report. Taken together, KLCM's Q1 moves show a firm pruning financial exposure in some spots while building it in others. The quarter was defined by deliberate, targeted shifts — not broad sweeping changes.
Publishers
12
Articles
7
Reach
19